Do hormonal changes with age influence sexual preferences in women?
This fact-check may be outdated. Consider refreshing it to get the most current information.
Executive summary
Hormonal changes across the menstrual cycle and with aging—especially the rise and fall of estradiol, progesterone, and androgens—are reliably linked to shifts in sexual desire and some mating-related preferences in women, but the effects on core sexual orientation or stable partner preference are limited and contested in the literature [1] [2] [3]. Menopause and the associated decline in estrogens and androgens commonly reduce sexual desire and cause physiological changes that affect sexual activity, yet psychosocial factors, partner dynamics, and methodological variability complicate causal claims [4] [5] [3].
1. Hormones over the short term: cycle-linked nudges in desire and mate choice
Multiple prospective, within-woman studies find that fluctuations in ovarian hormones—primarily rising estradiol around ovulation and higher progesterone in the luteal phase—are associated with measurable changes in sexual desire and some extra-pair mate preferences, such as increased attraction to cues of masculinity or physical strength during higher-fertility windows [1] [6] [2]. These effects are often subtle, vary by the sexual facet measured (desire versus arousal versus partner evaluation), and are moderated by contextual factors like partner attractiveness and contraceptive use, which can blunt cyclical shifts [6] [7].
2. Aging and menopause: larger hormonal shifts, clearer effects on libido and physiology
The transition to menopause involves sustained declines in estrogens and often androgens, and this life-stage is consistently linked to decreases in sexual desire, vaginal dryness, painful intercourse, and higher rates of sexual dysfunction—outcomes that are plausibly hormonal but also involve sleep disruption, health comorbidities, and relationship changes [4] [8] [5]. Clinical bodies and reviews report that estrogen therapy can remedy some physiologic barriers (vaginal atrophy) and that androgen levels correlate with libido in some studies, although therapeutic responses are heterogeneous and not fully understood [4] [8] [5].
3. Orientation and core partner preference: what hormones can and cannot explain
Experimental and developmental biology work shows that prenatal sex steroids organize later partner preference in many species, suggesting early hormonal exposure contributes to sexual orientation trajectories, but human evidence does not support simple adult hormonal switching of sexual orientation; adult hormonal fluctuations typically do not rewrite a person's enduring sexual orientation [9]. The human literature reviewed here finds hormone-linked modulation of sexual interest or preference signals rather than wholesale changes in whom women are fundamentally attracted to, and observational studies caution that reported midlife shifts in identity may reflect complex psychosocial processes as well as biology [9] [10].
4. Methodological caveats: heterogeneity, measurement, and nonhormonal confounds
A consistent theme across reviews and large-sample projects is mixed replication, measurement noise in hormone assays, wide between-woman variability, and powerful nonhormonal influences—partner behavior, sleep, pain, medications—that make isolating hormone effects difficult; some high-powered studies fail to replicate specific partner-preference cycle effects while still affirming links to sexual desire [7] [1] [11]. Hormonal contraceptives further complicate interpretation because they suppress cyclical hormones and may change sexual functioning differently across individuals, creating selection and reverse-causality risks in observational work [7].
5. Competing interpretations and hidden agendas in the literature
Evolutionary accounts frame cycle-linked shifts as adaptive mating strategies (good-genes hypotheses), and some researchers emphasize biological causation, while critics highlight inconsistent replication and social confounds; funding sources, disciplinary commitments (evolutionary psychology vs. clinical endocrinology), and media simplification can amplify certain narratives over nuanced findings [1] [2] [7]. Clinical sources prioritize symptom relief and quality of life and therefore emphasize treatment effects and heterogeneity, which can be framed as either evidence for hormonal causality or evidence of multifactorial causes [4] [8].
6. Bottom line for the central question
Hormonal changes with age do influence aspects of women’s sexual desire, physiology, and sometimes short-term preferences—particularly around ovulation and across menopause—but they do not, on the balance of available evidence, produce wholesale, reliable switches in sexual orientation or immutable partner choice; the magnitude and direction of effects are modest, individualized, and intertwined with psychosocial context and methodological limitations [1] [3] [9]. Where clinical implications exist—e.g., treating vaginal atrophy or severe hypoactive sexual desire in menopause—hormone-based interventions can help some women, but responses vary and nonhormonal factors must be addressed as well [4] [8] [5].